Correlates of ultrasound diagnosed non alcoholic fatty liver disease in Indian adults with features of metabolic syndrome

Imran Nazir Salroo 1, Musharaf Bashir 2 * , Rayees Ahmad Bhat 2, Sheikh Imran Sayeed 2
More Detail
1 Radiodiagnosis Department, SKIMS Medical College, Bemina, Srinagar, Jammu and Kashmir, India
2 Physiology Department, Government Medical College, Srinagar, Jammu and Kashmir, India
* Corresponding Author
J CLIN MED KAZ, Volume 1, Issue 55, pp. 17-21. https://doi.org/10.23950/1812-2892-JCMK-00732
OPEN ACCESS 2230 Views 1987 Downloads
Download Full Text (PDF)

ABSTRACT

Because of its complex pathogenesis and scarcity of approved therapies, non-alcoholic fatty liver disease is considered as one of the major challenge before mankind. Literature suggests that non-alcoholic fatty liver disease will replace Hepatitis C as a major form of chronic liver disease in adults and children over the next decade thus becoming the major cause of liver transplantation.
Aim: To assess anthropometric, biochemical parameters and correlates of ultrasound-diagnosed non-alcoholic fatty liver disease patients.
Material and methods: For this study a total of 182 subjects were selected from the department of Radiodiagnosis and Imaging, SKIMS medical college, Bemina, Srinagar, Jammu and Kashmir, India. Control group consisted of 91 age and sex matched subjects (mean age 51.69 ± 13.97 years) whereas case group consisted of 91 subjects (mean age 50.72 ± 12.13 years). Ultrasound under standardized conditions was performed in all subjects and the grading of non-alcoholic fatty liver disease was done in case group. Correlation of anthropometric and biochemical parameters with the non-alcoholic fatty liver disease was sought from the case group.
Results: Non-alcoholic fatty liver disease patients had significantly higher body mass index [BMI (p<0.0001***)] and waist-to-hip ratio (p<0.003**), fasting glucose levels (p<0.0001***) and triglycerides (p<0.0001***). Furthermore, a positive correlation between the waist (inches) and non-alcoholic fatty liver disease was found.
Conclusion: Our findings further support that patients with signs of metabolic syndrome are at increased risk to develop non-alcoholic fatty liver disease. Furthermore abdominal obesity is an independent risk factor for non-alcoholic fatty liver disease.
Keywords: non-alcoholic fatty liver disease (NAFLD), body mass index (BMI), abdominal obesity, waist, ultrasound

CITATION

Salroo IN, Bashir M, Bhat RA, Sayeed SI. Correlates of ultrasound diagnosed non alcoholic fatty liver disease in Indian adults with features of metabolic syndrome. Journal of Clinical Medicine of Kazakhstan. 2020;1(55):17-21. https://doi.org/10.23950/1812-2892-JCMK-00732

REFERENCES

  • Johannes W, Rau M, Andreas G. Non-alcoholic fatty liver disease: Epidemiology, Clinical course, Investigation and Treatment. Dtsch Arztebl Int. 2014; 111(26):447-52.
  • Younossi ZM, Giulio M, Helena PC, Salvatore P. Epidemiology of Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation. Transplantation. 2019; 103(1):22-7. https://doi.org/10.1097/TP.0000000000002484
  • Dharmalingham M, Yamasandhi PG. Non alcoholic fatty liver disease and Type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018; 22(3):421-28. https://doi.org/10.4103/ijem.IJEM_585_17
  • Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015; 313:2263-73. https://doi.org/10.1001/jama.2015.5370
  • Brunt EM et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015; 15080. https://doi.org/10.1038/nrdp.2015.80
  • Wong RJ et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015; 148:547-55. https://doi.org/10.1053/j.gastro.2014.11.039
  • Yang S, Kwak S, Lee JH, Kang S, Lee SP. Non alcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population. PLOS ONE. 2019; 14(11). https://doi.org/10.1371/journal.pone.0224626
  • Rodriguez SM, Margareth D, Filho M, Moraes JE. Metabolic syndrome and risk factors for non alcoholic fatty liver disease. Arq Gastroenterol. 2012; 49(1):89-96. https://doi.org/10.1590/S0004-28032012000100015
  • Duseja A. Nonalcoholic fatty liver disease in India - a lot done, yet more required! Indian J Gastroenterol 2010; (29):217-25. https://doi.org/10.1007/s12664-010-0069-1
  • AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002; 123:1705-25. https://doi.org/10.1053/gast.2002.36572
  • Benedict M, Zhano X. Non alcoholic fatty liver disease: An expanded review. World J Hepatol. 2017; 9(16):715-32. https://doi.org/10.4254/wjh.v9.i16.715
  • Singh SP, Nayak S, Swain M, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Indian J Gastroenterol. 2004; 25:76-9.
  • Duseja A, Bhansali A, Bhadada S, Jain P, Dhiman RK, Chawla Y. Nonalcoholic fatty liver disease in patients with recent onset type 2 diabetes mellitus (abstract). J Gastroenterol Hepatol. 2004; 19:A402.
  • Khov N, Sharma A, Riley TR. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(22):6821-25. https://doi.org/10.3748/wjg.v20.i22.6821
  • Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol. 2010; 52:579-585. https://doi.org/10.1016/j.jhep.2010.01.008
  • Singh SP, Nayak S, Swain M, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Indian J Gastroenterol. 2004; 25:76-9. 
  • Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010; 51:1593-602. https://doi.org/10.1002/hep.23567
  • Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition. 2003; 19:457-66. https://doi.org/10.1016/S0899-9007(02)01003-1
  • Kim HC, Choi SH, Shin HW, Cheong JY, Lee KW, Lee HC et al. Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women. World J Gastroenterol. 2005; 11:5314-21. https://doi.org/10.3748/wjg.v11.i34.5314
  • Mona AH et al. Liver ultrasound is more sensitive in assessing the severity of nonalcoholic fatty liver disease with homeostasis model assessment-insulin resistance. Egyptian Liver Journal. 2012; 2:41-6. https://doi.org/10.1097/01.ELX.0000412375.06564.cd
  • Mittendorfer B, Yoshino M, Patterson BW, Klein S. VLDL Triglyceride kinetics in lean, overweight and obese men and women. J Clin Endocrinol Metab. 2016; 101(11):4151-60. https://doi.org/10.1210/jc.2016-1500
  • Nayak NC, Vasdev N, Saigal S, Soin AS. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol. 2010; 41:425-30. https://doi.org/10.1016/j.humpath.2009.06.021
  • Gupte P, Amarapurkar D, Agal S, et al. Non alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004; 19:854-8. https://doi.org/10.1111/j.1440-1746.2004.03312.x
  • Kirvoski G et al. Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. Int J Clin Exp Med. 2010; 3(3): 202-10. https://doi.org/10.1055/s-0029-1246560